[Federal Register: March 27, 2003 (Volume 68, Number 59)]
[Notices]               
[Page 14967]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27mr03-30]                         

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy

 
Notice of Intent To Grant Exclusive Patent License; American 
BioHealth Group, LLC

AGENCY: Department of the Navy, DOD

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to American BioHealth Group, LLC, a revocable, nonassignable, 
exclusive license in the United States to practice, with right to 
sublicense, the Government-owned invention described in U.S. Patent 
Application Serial No. 09/766, 625, entitled ``Prevention or Reversal 
of Sensorial Hearing Loss Through Biological Mechanisms,'' filed 
January 23, 2001.

DATES: Anyone wishing to object to the granting of this license has 
(15) days from the date of this notice to file written objections along 
with supporting evidence, if any.

ADDRESSES: Written objections are to be filed with the Office of 
Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave, Silver Spring, MD 20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office 
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave, Silver Spring, MD 20910-7500, telephone (301) 319-7428, fax (301) 
319-7432, or E-Mail: schlagelc@nmrc.navy.mil.
    Dated: March 14, 2003.
R. E. Vincent II,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, 
Federal Register Liaison Officer.
[FR Doc. 03-7351 Filed 3-26-03; 8:45 am]